Medical device firm gains regulatory approval for new product

Catalyst OrthoScience aims to address multiple needs in the shoulder arthroplasty market.


  • By
  • | 2:33 p.m. March 19, 2021
Courtesy. Catalyst Chairman and CEO Brian Hutchison.
Courtesy. Catalyst Chairman and CEO Brian Hutchison.
  • Charlotte–Lee–Collier
  • Share

NAPLES — Catalyst OrthoScience, a Naples-based medical device company focused on the upper extremity orthopedics market recently received approval from the FDA to market its reverse shoulder system.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content